Showing results (371-380 of 405) with videos related to
Sort By:
Pageof 41
Plos One|February 24, 2017
Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and genderGeorgette D Kanmogne, Fang Qiu, Félicien E Ntone, et al.Journal of Immunological Methods|December 31, 2021
Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigenJing Xu, Haoyi Zhang, Chan Wang, et al.Breast Cancer Research and Treatment|January 25, 2012
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patientsXiangshan Zhao, Sameer Mirza, Alaa Alshareeda, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2017
Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac FibrosisYu Liu, Dan Zhao, Fang Qiu, et al.Journal of Translational Autoimmunity|December 10, 2024
Development of a standardized monoclonal antibody to the inner lipoyl domain of PDC-E2 as a potential international AMA referenceZhuye Qin, Fangming Cheng, Mingming Zhang, et al.Clinical Reviews in Allergy & Immunology|October 27, 2025
The Genomics/Genetics of Primary Biliary Cholangitis: The Case for a Functional SNP rs10893900 in ETS1/FLI1 and Review of the LiteratureMingming Zhang, Chan Wang, Yexi Huang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patientsDiana F Florescu, Steven A Pergam, Michael N Neely, et al.The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.Oncotarget|May 20, 2017
Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylationYu Liu, Duo Li, Dan Nie, et al.Pageof 41